Meribank Biotech Co., Ltd (4724.TWO)

TWD 28.55

(-1.89%)

Market Cap (In TWD)

2.51 Billion

Revenue (In TWD)

234.34 Million

Net Income (In TWD)

-125.34 Million

Avg. Volume

397.55 Thousand

Currency
TWD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
28.15-46.3
PE
-
EPS
-
Beta Value
0.0
ISIN
TW0004724000
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Shiyang Wu
Employee Count
-
Website
https://www.meribank.com.tw
Ipo Date
2023-06-16
Details
Meribank Biotech Co., Ltd manufactures, develops, and stores mesenchymal stem cells in Taiwan. The company engages in storage of placental umbilical cord mesenchymal stem cells, cord blood hematopoietic stem cells, and immune cells. It is also involved in cell cryopreservation protocol and postpartum nursing services. Meribank Biotech Co., Ltd was founded in 2013 and is based in Taipei City, Taiwan.